Scarica l'app Stockscreener
1.2574
1.38%
0.0174
Precedente Chiudi:
$1.24
Aprire:
$1.23
Volume 24 ore:
222.82K
Relative Volume:
0.13
Capitalizzazione di mercato:
$478.58M
Reddito:
$106.34M
Utile/perdita netta:
$-74.66M
Rapporto P/E:
-1.3236
EPS:
-0.95
Flusso di cassa netto:
$-46.12M
1 W Prestazione:
-6.88%
1M Prestazione:
+23.25%
6M Prestazione:
-28.98%
1 anno Prestazione:
-45.81%
Intervallo 1D:
$1.21
$1.26
Intervallo di 1 settimana:
$1.21
$1.35
Portata 52W:
$0.92
$2.41
Standard Biotools Inc Stock (LAB) Company Profile
Nome
Standard Biotools Inc
Settore
Industria
Telefono
(650) 266-6000
Indirizzo
2 TOWER PLACE, SOUTH SAN FRANCISCO
Confronta LAB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.26 | 491.29M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
121.22 | 231.78B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.90 | 152.32B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
388.60 | 149.83B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.00 | 114.03B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.19 | 45.28B | 5.54B | 4.18B | 623.10M | 7.00 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-27 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-04-16 | Iniziato | TD Cowen | Buy |
| 2024-04-04 | Iniziato | Jefferies | Buy |
| 2023-07-12 | Iniziato | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Borsa (LAB) Ultime notizie
What makes Standard BioTools Inc. stock price move sharplyFree Investment Group - Newser
Why Standard BioTools Inc. stock attracts strong analyst attentionReturn Optimized Trade Insights - Newser
How Standard BioTools Inc. stock performs during market volatilityProven Win Setups - Newser
Standard BioTools Inc.'s (NASDAQ:LAB) P/S Is Still On The Mark Following 26% Share Price Bounce - simplywall.st
Standard BioTools jumps on sale of SomaLogic to Illumina - MSN
Illumina to Acquire SomaLogic for $350 Million, Expanding into Proteomics and Precision Medicine - MSN
Illumina Stock May Benefit From New Agreement to Acquire SomaLogic - Nasdaq
Standard BioTools stock soars after selling SomaLogic to Illumina for $425M - Investing.com UK
Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy - Finansavisen
With 48% stake, Standard BioTools Inc. (NASDAQ:LAB) seems to have captured institutional investors' interest - Yahoo
Deeper Dive: Understanding Standard BioTools Inc (LAB) Through its Various Ratios - DWinneX
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Stock Holdings in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Standard BioTools Inc. (NASDAQ:LAB) Shares Bought by Bank of America Corp DE - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Shares Sold by California State Teachers Retirement System - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $970,000 Stock Position in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Shares Sold by Two Sigma Investments LP - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Stake Cut by Nuveen Asset Management LLC - Defense World
Standard BioTools: Too Early To Determine The Fate Of This Turnaround (NASDAQ:LAB) - Seeking Alpha
ProShare Advisors LLC Buys 27,334 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
BNP Paribas Financial Markets Decreases Stake in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Insider Selling: Standard BioTools Inc. (NASDAQ:LAB) SVP Sells 13,217 Shares of Stock - MarketBeat
Jane Street Group LLC Has $414,000 Holdings in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools to Host Inaugural “Proteomics Roundtable” Webc - GuruFocus
Standard BioTools (LAB) Unveils Proteomics Roundtable Series | L - GuruFocus
Standard BioTools (LAB) Unveils Proteomics Roundtable Series | LAB Stock News - GuruFocus
Deutsche Bank AG Increases Holdings in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools to Host Inaugural 'Proteomics Roundtable” Webcast Series - The Manila Times
Standard BioTools to Host Inaugural “Proteomics Roundtable” Webcast Series - GlobeNewswire
Standard BioTools to host inaugural ‘Proteomics Roundtable’ series - TipRanks
Top Executive Sells Thousands of Standard BioTools Shares! - TipRanks
Standard biotools CEO Michael Egholm sells $5,150 in stock By Investing.com - Investing.com Canada
Standard biotools CEO Michael Egholm sells $5,150 in stock - Investing.com
Standard biotools CEO Michael Egholm sells $5,126 in stock By Investing.com - Investing.com Canada
Standard biotools CEO Michael Egholm sells $5,126 in stock - Investing.com
Further weakness as Standard BioTools (NASDAQ:LAB) drops 15% this week, taking five-year losses to 79% - simplywall.st
Standard BioTools Inc. (NASDAQ:LAB) Stocks Pounded By 26% But Not Lagging Industry On Growth Or Pricing - simplywall.st
Standard biotools executive sells $25,784 in stock By Investing.com - Investing.com South Africa
Standard biotools executive sells $25,784 in stock - Investing.com India
Standard Biotools CEO Michael Egholm sells shares worth $4,860 - Investing.com Australia
Standard Biotools CEO Michael Egholm sells shares worth $4,860 By Investing.com - Investing.com India
Standard Biotools Inc Azioni (LAB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.59%
0.29%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):